Selected article for: "cardiovascular disease diabetes and chronic underlying disease"

Author: Zhenhua Zeng; Tong Sha; Yuan Zhang; Feng Wu; Hongbin Hu; Haijun Li; Jiafa Han; Wenhong Song; Qiaobing Huang; Zhongqing Chen
Title: Hypertension in patients hospitalized with COVID-19 in Wuhan, China: A single-center retrospective observational study
  • Document date: 2020_4_11
  • ID: lujxql3a_41
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20054825 doi: medRxiv preprint 15 likely to have underlying comorbidities, including chronic renal insufficiency, cardiovascular disease, diabetes mellitus, and cerebrovascular disease. Patients with hypertension tended to have a longer time from onset to admission and have higher positive COVID-19 PCR detection rates. Patients with hy.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20054825 doi: medRxiv preprint 15 likely to have underlying comorbidities, including chronic renal insufficiency, cardiovascular disease, diabetes mellitus, and cerebrovascular disease. Patients with hypertension tended to have a longer time from onset to admission and have higher positive COVID-19 PCR detection rates. Patients with hypertension who had taken ACEI/ARB drugs for antihypertensive treatment have an increased tendency to develop severe pneumonia after infection with SARS-COV-2. In future studies, a larger sample size and multi-center clinical data will be needed to support our conclusions.

    Search related documents:
    Co phrase search for related documents
    • antihypertensive treatment and cardiovascular disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • antihypertensive treatment and cerebrovascular disease: 1
    • antihypertensive treatment and chronic renal insufficiency: 1
    • antihypertensive treatment and future study: 1
    • antihypertensive treatment and hypertension patient: 1
    • antihypertensive treatment and increase tendency: 1
    • antihypertensive treatment and renal insufficiency: 1
    • antihypertensive treatment and sample size: 1, 2, 3
    • antihypertensive treatment and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • antihypertensive treatment and SARS infection severe pneumonia develop: 1, 2
    • antihypertensive treatment and severe pneumonia: 1, 2, 3, 4
    • antihypertensive treatment and severe pneumonia develop: 1, 2
    • cardiovascular disease and cerebrovascular disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • cardiovascular disease and chronic renal insufficiency: 1, 2, 3, 4, 5
    • cardiovascular disease and conclusion support: 1
    • cardiovascular disease and detection rate: 1, 2, 3, 4
    • cardiovascular disease and future study: 1, 2, 3, 4
    • cardiovascular disease and higher positive pcr detection rate: 1
    • cardiovascular disease and hypertension patient: 1, 2, 3, 4, 5, 6, 7